熱海　徹

平成１０年３月　慶應大学医学部修士終了

平成1４年3月 大阪大学大学院医学系研究科博士課程病理系専攻修了(腫瘍病理）

平成14 年４月　理化学研究所　免疫・アレルギー科学総合研究センター　ポスドク研究員

6) Atsumi, T*., K. Ishihara*, D. Kamimura, H. Ikushima, T. Ohtani, S. Hirota, H. Kobayashi, S-.J. Park, Y. Saeki, Y. Kitamura, and T. Hirano. (*equal contribution). submitted.

5) Kamimura, D., D. Fu, Y. Matsuda, T. Atsumi, T. Ohtani, S. J. Park, K. Ishihara, T. Hirano. Tyrosine 759 of the cytokine receptor gp130 is involved in Listeria monocytogenes susceptibility. Genes and Immunity. in press.

4) Narimatsu, M., H. Maeda, S. Itoh, T. Atsumi, T. Ohtani, K. Nishida, M. Itoh, D. Kamimura, S.-J. Park, K. Mizuno, J. Miyazaki, M. Hibi, K. Ishihara, K. Nakajima and T. Hirano. Tissue-specific autoregulation of the stat3 gene and its role in interleukin 6-induced survival signals in T cells. Mol. Cell. Biol. 21:6615-6625, 2001 (PubMed).

3) Ohtani, T., K. Ishihara, T. Atsumi, K. Nishida, Y. Kaneko, T. Miyata�, S. Itoh, M. Narimatsu, H. Maeda, T. Fukada､, M. Itoh, H. Okano, M. Hibi and T. Hirano. Dissection of signaling cascades through gp130 in vivo: Reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity, 12, 95-105, 2000. (PubMed) (Full Text in Immunity)

2) Ohtani, T., K. Ishihara, T. Atsumi, Y. Yoshida, K. Nishida, M. Narimatsu, T. Shirogane, M. Hibi and T. Hirano. gp130-mediated signalings as therapeutic targets. Emerging Therapeutic Targets,4, 459-479, 2000.

1) Nishida, K., Y. Yoshida, M. Itoh, T. Fukada, T. Ohtani, T. Shirogane, T. Atsumi, M. Takahashi-Tezuka, K. Ishihara, M. Hibi, and T. Hirano. Gab-family adapter proteins act downstream of cytokine and growth factor receptors, and T and B cell antigen receptors. Blood, 93:1809-1816, 1999.(PubMed)